Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH have been awarded a grant of over half a million pounds to test in clinical practice new technology designed to improve cancer care.
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.